European Journal of Cancer · 2019 · 178 citations · 33 references
MedicineOncologySurgeryChemotherapyOncologic SurgerySurgical OncologyCancer MortalityCancer RegistriesCancer Survival AnalysisMalignant NeoplasmsPancreatic CancerPancreatic SurgeryCancer Registry MethodologyKaplan-meier Survival EstimatesOverall MortalityPancreatic Cancer EpidemiologyPancreatic Cancer ResectionRegistry-based Survival Statistics
33
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 15K citations · Full text
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena et al. · New England Journal of Medicine · 2013 · 6.7K citations
Medicine, Oncology, Pharmacology +13
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Thierry Conroy, Pascal Hammel, Mohamed Hebbar et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text
Medicine, Oncology, Pharmacology +14